Oscar Health's Q2 2025: Key Contradictions in Risk Adjustments, Membership Trends, and Market Positioning
Generated by AI AgentAinvest Earnings Call Digest
Wednesday, Aug 6, 2025 9:46 pm ET1min read
OSCR--
Aime Summary
Aime SummaryRisk adjustment payable as a percentage of revenue, future membership trends, risk adjustment payable as a percentage of premiums, and market stability and competitive positioning are the key contradictions discussed in Oscar Health's latest 2025Q2 earnings call.
Revenue and Membership Growth:
- Oscar HealthOSCR--, Inc. reported total revenue of $2.9 billion for Q2 2025, a 29% increase year-over-year.
- Membership grew by 28% year-over-year, reaching more than 2 million members.
- The growth was driven by strong retention, above-market growth during open enrollment, and continuing SEP member additions.
Medical Loss Ratio (MLR) and Risk Adjustment Payable:
- The second-quarter medical loss ratio (MLR) increased by 12 points year-over-year to 91.1%.
- This increase was primarily due to a $316 million increase to the risk adjustment payable for 2025.
- The rise in MLR was attributed to higher average market morbidity, driven by the entry of consumers into the individual market for Medicaid redeterminations and healthier, low-utilizing consumers leaving the market.
Financial Performance and Guidance:
- Oscar reported a loss from operations of $230 million and an adjusted EBITDA loss of $199 million for Q2 2025.
- The company reaffirmed its updated 2025 guidance, including revenue of $12 billion to $12.2 billion and a loss from operations of $200 million to $300 million.
- The guidance was revised based on better-than-expected retention and higher SEP member additions, amidst a market-wide shift towards higher average market morbidity.
Strategic Initiatives for Market Stability:
- Oscar is implementing a series of strategic steps to address market instability, including submitting 2026 rate filings and partnering with consumer brands to expand its market reach.
- The company is focused on stabilizing the market in 2026 by addressing morbidity pressure and the effects of program integrity efforts through rate increases.
- These initiatives are aimed at ensuring a return to profitability in 2026 and long-term growth.
Revenue and Membership Growth:
- Oscar HealthOSCR--, Inc. reported total revenue of $2.9 billion for Q2 2025, a 29% increase year-over-year.
- Membership grew by 28% year-over-year, reaching more than 2 million members.
- The growth was driven by strong retention, above-market growth during open enrollment, and continuing SEP member additions.
Medical Loss Ratio (MLR) and Risk Adjustment Payable:
- The second-quarter medical loss ratio (MLR) increased by 12 points year-over-year to 91.1%.
- This increase was primarily due to a $316 million increase to the risk adjustment payable for 2025.
- The rise in MLR was attributed to higher average market morbidity, driven by the entry of consumers into the individual market for Medicaid redeterminations and healthier, low-utilizing consumers leaving the market.
Financial Performance and Guidance:
- Oscar reported a loss from operations of $230 million and an adjusted EBITDA loss of $199 million for Q2 2025.
- The company reaffirmed its updated 2025 guidance, including revenue of $12 billion to $12.2 billion and a loss from operations of $200 million to $300 million.
- The guidance was revised based on better-than-expected retention and higher SEP member additions, amidst a market-wide shift towards higher average market morbidity.
Strategic Initiatives for Market Stability:
- Oscar is implementing a series of strategic steps to address market instability, including submitting 2026 rate filings and partnering with consumer brands to expand its market reach.
- The company is focused on stabilizing the market in 2026 by addressing morbidity pressure and the effects of program integrity efforts through rate increases.
- These initiatives are aimed at ensuring a return to profitability in 2026 and long-term growth.
Discover what executives don't want to reveal in conference calls
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet